NeuroTalk Support Groups

NeuroTalk Support Groups (https://www.neurotalk.org/)
-   Parkinson's Disease Clinical Trials (https://www.neurotalk.org/parkinson-s-disease-clinical-trials/)
-   -   Safinamide..Merck Serono Announces 18-Month Safety and Efficacy Data Phase III Trial (https://www.neurotalk.org/parkinson-s-disease-clinical-trials/26921-safinamide-merck-serono-announces-18-month-safety-efficacy-data-phase-iii-trial.html)

Stitcher 08-29-2007 12:41 PM
Safinamide..Merck Serono Announces 18-Month Safety and Efficacy Data Phase III Trial
 
Merck Serono Announces 18-Month Safety and Efficacy Data of Phase III Trial of Safinamide. Additional trials expected to be initiated (8/ 22/07)

See Focus on Therapies


All times are GMT -5. The time now is 07:40 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.